Report Detail
Global Diabetes Treatment Market Insights, Forecast to 2025
- RnM2690955 |
- 12 June, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved people's living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end of 2025, growing at a CAGR of 3.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Diabetes Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Diabetes Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Diabetes Treatment in these regions.
This research report categorizes the global Diabetes Treatment market by top players/brands, region, type and end user. This report also studies the global Diabetes Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novo Nordisk
Bayer
Teva Pharmaceuticals Pvt Ltd.
Merck＆Company Inc.
Medtronic Inc.
Johnson＆Johnson
Home Diagnostics Inc.
Amylin Pharmaceuticals Inc.
Abbott Laboratories
Market size by Product
Insulin
Oral Hypoglycaemic Drugs
Non-Insulin Injectable Drugs
Market size by End User
Hospital
Personal Use
Clinic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Diabetes Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Diabetes Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Diabetes Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Diabetes Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Diabetes Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Diabetes Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Diabetes Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Diabetes Treatment Market Size Growth Rate by Product
- 1.4.2 Insulin
- 1.4.3 Oral Hypoglycaemic Drugs
- 1.4.4 Non-Insulin Injectable Drugs
- 1.5 Market by End User
- 1.5.1 Global Diabetes Treatment Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Personal Use
- 1.5.4 Clinic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Diabetes Treatment Market Size
- 2.1.1 Global Diabetes Treatment Revenue 2014-2025
- 2.1.2 Global Diabetes Treatment Sales 2014-2025
- 2.2 Diabetes Treatment Growth Rate by Regions
- 2.2.1 Global Diabetes Treatment Sales by Regions
- 2.2.2 Global Diabetes Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Diabetes Treatment Sales by Manufacturers
- 3.1.1 Diabetes Treatment Sales by Manufacturers
- 3.1.2 Diabetes Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Diabetes Treatment Revenue by Manufacturers
- 3.2.1 Diabetes Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Diabetes Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Diabetes Treatment Price by Manufacturers
- 3.4 Diabetes Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Diabetes Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Diabetes Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Diabetes Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Diabetes Treatment Sales by Product
- 4.2 Global Diabetes Treatment Revenue by Product
- 4.3 Diabetes Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Diabetes Treatment Breakdown Data by End User
6 North America
- 6.1 North America Diabetes Treatment by Countries
- 6.1.1 North America Diabetes Treatment Sales by Countries
- 6.1.2 North America Diabetes Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Diabetes Treatment by Product
- 6.3 North America Diabetes Treatment by End User
7 Europe
- 7.1 Europe Diabetes Treatment by Countries
- 7.1.1 Europe Diabetes Treatment Sales by Countries
- 7.1.2 Europe Diabetes Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Diabetes Treatment by Product
- 7.3 Europe Diabetes Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Diabetes Treatment by Countries
- 8.1.1 Asia Pacific Diabetes Treatment Sales by Countries
- 8.1.2 Asia Pacific Diabetes Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Diabetes Treatment by Product
- 8.3 Asia Pacific Diabetes Treatment by End User
9 Central & South America
- 9.1 Central & South America Diabetes Treatment by Countries
- 9.1.1 Central & South America Diabetes Treatment Sales by Countries
- 9.1.2 Central & South America Diabetes Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Diabetes Treatment by Product
- 9.3 Central & South America Diabetes Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Diabetes Treatment by Countries
- 10.1.1 Middle East and Africa Diabetes Treatment Sales by Countries
- 10.1.2 Middle East and Africa Diabetes Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Diabetes Treatment by Product
- 10.3 Middle East and Africa Diabetes Treatment by End User
11 Company Profiles
- 11.1 Novo Nordisk
- 11.1.1 Novo Nordisk Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Novo Nordisk Diabetes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Novo Nordisk Diabetes Treatment Products Offered
- 11.1.5 Novo Nordisk Recent Development
- 11.2 Bayer
- 11.2.1 Bayer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bayer Diabetes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bayer Diabetes Treatment Products Offered
- 11.2.5 Bayer Recent Development
- 11.3 Teva Pharmaceuticals Pvt Ltd.
- 11.3.1 Teva Pharmaceuticals Pvt Ltd. Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Teva Pharmaceuticals Pvt Ltd. Diabetes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Teva Pharmaceuticals Pvt Ltd. Diabetes Treatment Products Offered
- 11.3.5 Teva Pharmaceuticals Pvt Ltd. Recent Development
- 11.4 Merck＆Company Inc.
- 11.4.1 Merck＆Company Inc. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Merck＆Company Inc. Diabetes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Merck＆Company Inc. Diabetes Treatment Products Offered
- 11.4.5 Merck＆Company Inc. Recent Development
- 11.5 Medtronic Inc.
- 11.5.1 Medtronic Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Medtronic Inc. Diabetes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Medtronic Inc. Diabetes Treatment Products Offered
- 11.5.5 Medtronic Inc. Recent Development
- 11.6 Johnson＆Johnson
- 11.6.1 Johnson＆Johnson Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Johnson＆Johnson Diabetes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Johnson＆Johnson Diabetes Treatment Products Offered
- 11.6.5 Johnson＆Johnson Recent Development
- 11.7 Home Diagnostics Inc.
- 11.7.1 Home Diagnostics Inc. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Home Diagnostics Inc. Diabetes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Home Diagnostics Inc. Diabetes Treatment Products Offered
- 11.7.5 Home Diagnostics Inc. Recent Development
- 11.8 Amylin Pharmaceuticals Inc.
- 11.8.1 Amylin Pharmaceuticals Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Amylin Pharmaceuticals Inc. Diabetes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Amylin Pharmaceuticals Inc. Diabetes Treatment Products Offered
- 11.8.5 Amylin Pharmaceuticals Inc. Recent Development
- 11.9 Abbott Laboratories
- 11.9.1 Abbott Laboratories Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Abbott Laboratories Diabetes Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Abbott Laboratories Diabetes Treatment Products Offered
- 11.9.5 Abbott Laboratories Recent Development
12 Future Forecast
- 12.1 Diabetes Treatment Market Forecast by Regions
- 12.1.1 Global Diabetes Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Diabetes Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Diabetes Treatment Market Forecast by Product
- 12.2.1 Global Diabetes Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Diabetes Treatment Revenue Forecast by Product 2019-2025
- 12.3 Diabetes Treatment Market Forecast by End User
- 12.4 North America Diabetes Treatment Forecast
- 12.5 Europe Diabetes Treatment Forecast
- 12.6 Asia Pacific Diabetes Treatment Forecast
- 12.7 Central & South America Diabetes Treatment Forecast
- 12.8 Middle East and Africa Diabetes Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Diabetes Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Diabetes Treatment . Industry analysis & Market Report on Diabetes Treatment is a syndicated market report, published as Global Diabetes Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Diabetes Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
